Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konrad Talbot

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Neurodegenerative Disease Management|March 20, 2014
Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogsKonrad Talbot
Progress in Brain Research|March 23, 2010
The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia researchKonrad Talbot
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 18, 2014
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's diseaseKonrad Talbot, Hoau-Yan Wang
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisXuelin Gu, Tim Distel, Konrad Talbot
Progress in Brain Research|December 8, 2004
Neurodevelopment, neuroplasticity, and new genes for schizophreniaSteven E Arnold, Konrad Talbot, Chang-Gyu Hahn
Expert Review of Neurotherapeutics|May 24, 2014
Newly identified precipitating factors in mechanical ventilation-induced brain damage: implications for treating ICU deliriumAdrián González-López, Guillermo M Albaiceta, Konrad Talbot
Biochemical Pharmacology|August 7, 2020
Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeuticsTherese S Salameh, Elizabeth M Rhea, Konrad Talbot, et al.
Journal of the Neurological Sciences|April 9, 2018
Insulin resistance and cognitive test performance in elderly adults: National health and nutrition examination survey (NHANES)Ayesha Z Sherzai, Magda Shaheen, Jeffrey J Yu, et al.
Neurochemistry International|December 3, 2014
Oxidative stress reduces levels of dysbindin-1A via its PEST domainMei-Yi Alicia Yap, Yew-Long Lo, Konrad Talbot, et al.
Plos One|March 11, 2011
Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic locationKonrad Talbot, Natalia Louneva, Julia W Cohen, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Neurodegenerative Disease Management|March 20, 2014
Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogsKonrad Talbot
Progress in Brain Research|March 23, 2010
The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia researchKonrad Talbot
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 18, 2014
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's diseaseKonrad Talbot, Hoau-Yan Wang
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisXuelin Gu, Tim Distel, Konrad Talbot
Progress in Brain Research|December 8, 2004
Neurodevelopment, neuroplasticity, and new genes for schizophreniaSteven E Arnold, Konrad Talbot, Chang-Gyu Hahn
Expert Review of Neurotherapeutics|May 24, 2014
Newly identified precipitating factors in mechanical ventilation-induced brain damage: implications for treating ICU deliriumAdrián González-López, Guillermo M Albaiceta, Konrad Talbot
Biochemical Pharmacology|August 7, 2020
Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeuticsTherese S Salameh, Elizabeth M Rhea, Konrad Talbot, et al.
Journal of the Neurological Sciences|April 9, 2018
Insulin resistance and cognitive test performance in elderly adults: National health and nutrition examination survey (NHANES)Ayesha Z Sherzai, Magda Shaheen, Jeffrey J Yu, et al.
Neurochemistry International|December 3, 2014
Oxidative stress reduces levels of dysbindin-1A via its PEST domainMei-Yi Alicia Yap, Yew-Long Lo, Konrad Talbot, et al.
Plos One|March 11, 2011
Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic locationKonrad Talbot, Natalia Louneva, Julia W Cohen, et al.
Pageof 4